Overview

Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The study will assess the efficacy and safety of SPARC1310 when compared to placebo and active control
Phase:
Phase 2
Details
Lead Sponsor:
Sun Pharma Advanced Research Company Limited